Trial Search Results
Post‐Traumatic Stress Symptoms (PTSS) in Transplant Recipients
This study is conducted to better understand Post-Traumatic Stress Symptoms (PTSS) in adolescent transplant recipients and their parent/guardian and to see if PTSS play a role in the way adolescent transplant recipients take their prescribed medicine.
Target population: medically stable adolescent solid organ (e.g., heart, kidney, liver, lung, small bowel) transplant recipients and their parent(s)/guardian.
Stanford is currently not accepting patients for this trial.
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborator: Clinical Trials in Organ Transplantation in Children
- Other: Assessment of adherence, mental health, behavioral, quality of life and biological constructs
- and/or their parent(s)/guardian must be able to understand and provide informed
consent in English or Spanish;
- is prescribed tacrolimus (either brand or generic formulation); and
- has been seen in the enrolling center's clinic at least twice in the last two years.
- received a transplant less than 18 months prior to enrollment;
- has had more than one transplant (including marrow replacement);
- or their parent(s)/guardian is actively psychotic or severely disoriented due to any
cause, including hepatic encephalopathy (temporary exclusion);
- or their parent(s)/guardian has been diagnosed with severe intellectual disability as
defined in the Diagnostic and Statistical Manual of Mental Disorders, 5th edition
- is not medically stable or is hospitalized;
- is currently enrolled in a study that aims to improve adherence to medical
- is receiving cognitive behavioral therapy for confirmed or suspected diagnosis of
Post-Traumatic Stress Disorder (PTSD) at enrollment;
- is receiving psychotropic medications for a confirmed or suspected diagnosis of PTSD.
Ages Eligible for Study
12 Years - 17 Years
Genders Eligible for Study